
The Library Media — National & World · National Desk
Missouri Judge Gives Final Approval to Bayer’s $7.25 Billion Roundup Cancer Settlement
By Eleanor Ever Loyal
A Missouri judge on Friday gave final approval to Bayer’s nationwide $7.25 billion settlement resolving claims that its Roundup weedkiller caused cancer, establishing a compensation framework for people already diagnosed with non-Hodgkin lymphoma and others who may receive the diagnosis in future years. The agreement is among the largest mass-tort settlements in history, but Bayer continues to deny that Roundup causes cancer, and the underlying scientific dispute remains unresolved.
St. Louis Circuit Judge Timothy Boyer approved the agreement in a written judgment. Under its terms, Bayer will make annual payments into a special fund for as long as 21 years, with total payments reaching as much as $7.25 billion, according to Associated Press reporting carried by PBS NewsHour. The money is in addition to the $16 billion Bayer previously set aside for Roundup legal costs.
The settlement covers people who used Roundup and are already ill, as well as those diagnosed with non-Hodgkin lymphoma in future years, provided their exposure occurred before the agreement was proposed in February. It is designed to resolve most of the remaining lawsuits against the company. Monsanto and the plaintiffs reached the agreement in February, and it received preliminary approval in March, The Hill reported. A court hearing on its fairness took place in September.
About 200,000 Roundup-related claims have been made against Bayer, many involving people who used the weedkiller on residential lawns and gardens, according to the AP report. Individual compensation under the agreement could average between $10,000 and $165,000, depending on the claimant’s exposure, age at diagnosis and severity of illness. Agricultural, industrial and turf workers with lengthy exposure who were diagnosed with an aggressive form of the disease before age 60 could average $165,000. People diagnosed at age 78 or older would average $10,000.
Boyer described the average individual payouts as “fair and adequate” and called the overall agreement “among the largest in the history of mass tort personal-injury class action settlements,” according to the AP. The Hill reported that he also cited the Supreme Court’s June decision, noting that Monsanto had won a majority of related cases even before that ruling.
The lawsuits alleged that Bayer and its predecessor, Monsanto, should have warned users that Roundup could cause lymphoma. Plaintiffs argued that exposure to the product and its active ingredient, glyphosate, caused their non-Hodgkin lymphoma, a blood cancer. Bayer, a Germany-based company, denies that Roundup causes cancer. Neither the settlement approval nor the reports describe an admission of wrongdoing or liability by the company.
The scientific evidence remains contested. The World Health Organization’s International Agency for Research on Cancer classified glyphosate as “probably carcinogenic” in 2015. The U.S. Environmental Protection Agency, by contrast, has determined that glyphosate is not likely to cause cancer in humans when used as directed.
The settlement follows a significant legal development in June 2026, when the U.S. Supreme Court ruled that Bayer could not face state-court failure-to-warn claims because federal regulations do not require a cancer warning label and states cannot impose additional labelling requirements. Some attorneys representing patients have argued that the settlement payouts are too small. Others have said the agreement is better than nothing, a position made more likely by the Supreme Court ruling, the AP reported.
Bayer chief executive Bill Anderson said the court-approved settlement was “a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation.” Christopher A. Seeger, court-appointed counsel for the cancer patients, said: “Today’s final approval order delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice.”
The agreement also drew criticism at the September fairness hearing. Attorney Gerson Smoger called it “the scariest, worst future settlement that’s ever been contemplated.” He argued that it would bind future claimants for decades without the possibility of punitive damages while the product they had been exposed to remained on the market.
Monsanto introduced Roundup in 1974, with glyphosate as its active ingredient. The herbicide became widely used in agriculture, including with genetically modified seeds designed to resist it. Bayer acquired Monsanto in 2018 and inherited the litigation. Only a couple dozen cases have reached juries, with mixed results: a Georgia jury awarded plaintiffs $2.1 billion in one case, while a Missouri jury sided with Bayer in October in the first Roundup verdict since the Supreme Court ruling, according to the AP.
Bayer has already changed the formula of Roundup sold to residential users, removing glyphosate from new residential versions. The settlement does not order a ban or withdrawal. Although Bayer has considered pulling Roundup from U.S. agricultural markets because of litigation costs, it has made no such decision. The approval could be appealed. The reports do not specify an opt-out procedure, claims-filing process or payment start date.
Eleanor Ever Loyal
Lead Counsel & National Desk, The Library Media
From The Library — the estate of our family.
Follow Us